BURLINGTON, N.C.--(BUSINESS WIRE)--LabCorp® (NYSE: LH), a leading global life sciences company, announced today that it has received approval from the U.S. Food and Drug Administration (FDA) for the ...

Laboratory Corporation of America Holdings (LabCorp) is the first national clinical laboratory to offer HCV PCR testing using a newly FDA approved assay, the Roche COBAS AmpliPrep/COBAS TaqMan HCV ...

This faster polymerase chain test (PCR) allows same-day diagnosis and prompt treatment for the people affected with liver disease. This expeditious assessment aims to prevent costly and ruinous ...

According to a new study presented at The Liver Meeting, combining universal screening for the hepatitis C virus (HCV) with reflex RNA PCR in pregnant women is more cost-effective than risk-based ...

Chronic hepatitis C infection affects an estimated 50 million people globally, causes approximately 242,000 deaths per year mostly due to cirrhosis and liver cancer Same-day results will help ...

Agreement Significantly Adds to the North American Test Menus of Both Parties and Aims to Increase the Adoption of HPV Screening GERMANTOWN, Maryland and DES PLAINES ...

The FDA has greenlit its first point-of-care diagnostic test for hepatitis C, capable of using only a fingerstick blood sample, in a bid to quickly connect patients with antiviral drugs. “Despite the ...

To develop the new rapid polymerase chain reaction (PCR) test for HCV, the scientists used the DASH® (Diagnostic Analyzer for Specific Hybridization)PCR platform, which was originally developed at ...

Please provide your email address to receive an email when new articles are posted on . HCV testing provides valuable information that aids in disease prevention and in the initiation of care.

Hearts and lungs from donors with hepatitis C viremia are typically not transplanted. The advent of direct-acting antiviral agents to treat hepatitis C virus (HCV) infection has raised the possibility ...